Clozapine and associated QTc prolongation

Australian and New Zealand Journal of Psychiatry

Volumn 45, Issue 12, 2011, Pages 1098-1099

  Dhillon, Rohan ^a   Bastiampillai, Tarun ^a   Tee, Kristen ^a   Vanlint, Andrew ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; VALPROIC ACID;

ADULT; AGITATION; BRAIN DISEASE; CASE REPORT; CATATONIA; CONFUSION; DELUSION; DISEASE ASSOCIATION; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FEMALE; HALLUCINATION; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; QT PROLONGATION; SCHIZOAFFECTIVE PSYCHOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT RESPONSE; URINARY TRACT INFECTION;

CLOZAPINE; FEMALE; HUMANS; LONG QT SYNDROME; MIDDLE AGED;

EID: 82355182321     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2011.619163     Document Type: Letter

References (6)

1. Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158:1774-1782. (Pubitemid 33054769)
2. Taylor D, Paton C, Kerwin R. Schizophrenia. In: Taylor D, Paton C, Kerwin R, eds. The Maudsley prescribing guide lines , ninth edition. London: Informa Healthcare, 2007:118-119.
3. Warner B, Hoffmann P. Investigation of the potential of clozapine to cause torsade de pointes. Adverse Drug Reaction Toxicol Rev 2002; 21:189-203. (Pubitemid 36018766)
4. Bastiampillai T, Forooziya F, Dhillon R. Clozapine-withdrawal catatonia. Aust N Z J Psychiatry. 2009; 43:283-284.
5. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245. (Pubitemid 12149145)
6. Lee SY, Kim YJ, Kim KT, Choe H, Jo SH. Blockade of HERG human K ≤ channels and IKr of guinea-pig cardiomyocytes by the antipsychotic drug clozapine. Br J Pharmacol 2006; 148: 499-509. (Pubitemid 43882086)